Diprivander
ActiveSummary
Diprivander has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39,571 and a net result of €82,285. The computed 12-month bankruptcy probability is 1.1% (low).
Overview
- Equity
- €39,571
- Profit
- €82,285
Why 67raises risk1 change of registered office in 24 monthsFounded in 2025lowers riskSize: total assets €117,860Liquidity: current ratio 1.49, cash €41,519Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 35% on solvency, 55% on liquidity and 90% on profitability.
The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Searched, nothing found (1)
- Registered office · Other addresses ·…Registered-office move · Capital conversion…
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: JANSSENS Sander Jos (director)…
Financials · financial year 2025, micro format
Turnover and EBIT margin not published: the micro format does not require them.
Peer companies
Historical observationOf the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 96.6% are still going.
- Micro
- under 2 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
For this company itself Checked computes a higher bankruptcy probability: 1.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2025 |
|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €198 |
| Gross operating margin9900 | €107,278 |
| Operating profit (loss)9901 | €107,080 |
| Financial income75/76B | €0 |
| Recurring financial income75 | €0 |
| Financial charges65/66B | €3,284 |
| Recurring financial charges65 | €3,284 |
| Profit (loss) for the period before taxes9903 | €103,796 |
| Income taxes67/77 | €21,511 |
| Profit (loss) for the period9904 | €82,285 |
| Profit (loss) for the period to be appropriated9905 | €82,285 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €117,860 | |
| Fixed assets21/28 | €931 | |
| Tangible fixed assets22/27 | €931 | |
| Furniture and vehicles24 | €931 | |
| Current assets29/58 | €116,929 | |
| Cash at bank and in hand54/58 | €41,519 | |
| Deferred charges and accrued income490/1 | €75,410 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €117,860 | |
| Equity10/15 | €39,571 | |
| Contributions10/11 | €3,000 | |
| Reserves13 | €36,571 | |
| Distributable reserves133 | €36,571 | |
| Profit (loss) carried forward14 | €0 | |
| Amounts payable17/49 | €78,289 | |
| Amounts payable within one year42/48 | €78,289 | |
| Trade debts44 | €4,390 | |
| Suppliers440/4 | €4,390 | |
| Taxes, remuneration and social security45 | €27,311 | |
| Taxes450/3 | €24,811 | |
| Remuneration and social security454/9 | €2,500 | |
| Other amounts payable47/48 | €46,588 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | €82,285 |
| + Depreciation and write-downs630 | €198 |
| Operating cash flow (approximation) | €82,483 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 17-07-2026 | 2026-00306416 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| JANSSENS Sander Jos |
|
Owners and capital
Capital and shareholders
- JANSSENS Sander Jos 120 shares (100%)
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 03-09-2026 Capital conversion · none
- 23-01-2025 Incorporation · €3,000 · 120 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
03-09
Gazette deed
Registered office · Other addresses · Amendment of the articles · MiscellaneousRegistered-office move · Capital conversion · Capital10 facts ▸
- General meeting, 30-08-2026
- Registered-office move, 7520 Tournai-Templeuve, Rue de Roubaix 119
- Amendment of the articles, 2
- Capital conversion, “none” (deed in Dutch)
- Capital
- Board meeting, “verlengen alle bevoegdheden aan het bestuursorgaan voor de uitvoering van de voorgaande besluiten, assemblée générale” (deed in Dutch)
- Other provision, “Besluit tot verplaatsing van de maatschappelijke zetel van de vennootschap en tot aanpassing van de statuten dienovereenkomstig” (deed in Dutch)
- Other provision, “Vertaling van de statuten van de vennootschap in het Frans” (deed in Dutch)
- Other provision, “Volmachten” (deed in Dutch)
- Board meeting, “verlenen alle bevoegdheden aan het bestuursorgaan voor de uitvoering van de voorgaande besluiten, algemene vergadering” (deed in Dutch)
23-01
Gazette deed
IncorporationAppointment: JANSSENS Sander Jos (director) · Founder · Founding capital6 facts ▸
- Incorporation, 16-01-2025
- Founder, JANSSENS Sander Jos
- Founding capital, €3,000
- Bank account, 3000, “vennootschap in oprichting” (deed in Dutch)
- Director appointment, JANSSENS Sander Jos (director)
- Other provision, /, “Doel” (deed in Dutch)
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 22 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 34026A0631/00H000 | Flanders | 13.7 ha | 1 · 3.4 ha | - |
| 23050F0374/00T000 | Flanders | 741 m² | 1 · 440 m² | 11.6 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “L’exercice de la médecine, en Belgique et à l’étranger, pour son propre compte ou pour le compte de tiers, par un médecin actionnaire…” (deed in Dutch)deed of 03-09-2026
9 activities (deed in Dutch)
- L’exercice de la médecine, en Belgique et à l’étranger, pour son propre compte ou pour le compte de tiers, par un médecin actionnaire, notamment, mais sans s’y limiter, dans le domaine de l’anesthésie, dans le respect des règles de la déontologie médicale, à condition qu’il soit inscrit sur la liste de l’Ordre des médecins, étant entendu que tout ou partie des activités médicales sont exercées au nom et pour le compte de la société et que tous les honoraires qui en découlent sont perçus par et pour la société. La société veille à ce que les activités soient exercées dans le respect des prescriptions déontologiques et administratives, en observant les règles de la déontologie médicale et conformément aux principes de l’éthique médicale et aux exigences de la discipline scientifique. Plus précisément, elle veille à ce que le libre choix du médecin par le patient, la liberté diagnostique et thérapeutique ainsi que le respect du secret médical soient préservés. La société veille également à ce que l’indépendance professionnelle du médecin-actionnaire dans l’exercice de sa profession reste garantie et à ce qu’aucun motif ne donne lieu à une pratique commerciale de la médecine, à une collusion directe ou indirecte, à une dichotomie ou à une surconsommation.
- Les recettes provenant de l’activité médicale apportée sont perçues pour le compte et par la société, de même que toutes les dépenses découlant de l’activité médicale sont réglées par la société.
- La mise en place de services généraux et, en particulier, d’un secrétariat médical utiles ou nécessaires à l’exercice de l’activité susmentionnée
- L’achat, la location et/ou le crédit-bail de tous les équipements médicaux et locaux connexes, y compris les bâtiments, en somme, d’une infrastructure matérielle complète destinée à être mise à la disposition du médecin actionnaire
- La création de possibilités permettant au médecin actionnaire de se perfectionner dans la discipline médicale susmentionnée, afin de garantir une pratique de haute qualité
- La fourniture d’informations et/ou de formations en matière de médecine en général et d’anesthésie en particulier, au sens le plus large du terme, sans que cela ne prenne la forme d’une activité commerciale complémentaire
- La société peut réaliser des placements dans des biens mobiliers ou immobiliers ou investir ses ressources, à titre d’objet accessoire. Le placement ou l’investissement de ses ressources peut être financé par des emprunts
- La société peut participer à toutes les entreprises poursuivant un objet similaire, mais les accords que les médecins ne sont pas autorisés à conclure avec d’autres médecins ou avec des tiers ne pourront pas non plus être conclus par la société
- La société peut participer à des groupements de frais ou à des sociétés de mise en commun de ressources entre médecins. La société peut également être membre d’une association de médecins à but non lucratif. Tout cela en tenant compte des règles de déontologie médicale en la matière.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimiteddeed of 03-09-2026
- Name clauseThe name the company operates under according to its articles.
- Diprivanderdeed of 23-01-2025
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région Wallonne, La société peut établir, par simple décision de l’organe d’administration, des sièges administratifs, agences, ateliers…” (deed in Dutch)deed of 03-09-2026
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- 3 provisions in the deed
- Power of attorneyA special mandate allowing someone to perform one or more acts on the company's behalf.
- One provision in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- 2 provisions in the deed
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- 7 provisions in the deed
- Share issue ruleHow and by whom new shares can be issued.
- “Lorsque les actions ne sont pas entièrement libérées, l’organe de direction peut exiger le versement des fonds nécessaires à la libération…” (deed in Dutch)
- Financial instrumentSecurities other than shares, such as bonds or warrants, the company can issue.
- One provision in the deed
- Profit allocationHow profit is distributed; a BV may only pay out after a balance-sheet and liquidity test.
- “Simple des voix, organe de direction” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Second Friday of June at 19:00
- Voting ruleWhich majority the meeting decides by, for example a simple or a special majority.
- “Simple des voix, proposition rejetée” (deed in Dutch)“Suspension du droit de vote, versements dûment exigés et exigibles non effectués” (deed in Dutch)
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Formalités, quorums et majorités du Code des sociétés et des associations, assemblée générale” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- 2 provisions in the deed